| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.03 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.38 | 0.04 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |